SCHEMBL29970258

CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O

nearest known ligand 0.63

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	5/20	0.63

▸	GCGR	P47871	1/20	0.63

▸	GIPR	P48546	1/20	0.63

▸	TLR2	O60603	4/20	0.58

▸	IL23R	Q5VWK5	2/20	0.58

▸	RXFP1	Q9HBX9	4/20	0.56

▸	CCKBR	P32239	1/20	0.55

▸	PTH1R	Q03431	2/20	0.54

▸	ECE1	P42892	1/20	0.54

▸	MUS81	Q96NY9	1/20	0.54

▸	ERBB2	P04626	1/20	0.53

▸	NR3C1	P04150	1/20	0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30974407	0.92	ERBB2 (0.57)	GLP1RGCGRGIPRTLR2ERBB2
SCHEMBL31182787	0.91	GLP1R (0.65)	GLP1RGCGRGIPRTLR2IL23R
SCHEMBL30262019	0.91	GLP1R (0.59)	GLP1RGCGRGIPRTLR2IL23R
SCHEMBL29436295	0.90	KISS1R (0.56)	GLP1RGCGRGIPRTLR2IL23R
SCHEMBL29568978	0.89	TLR2 (0.65)	GLP1RGCGRGIPRTLR2RXFP1
SCHEMBL30262220	0.89	ERBB2 (0.62)	GLP1RGCGRGIPRTLR2RXFP1
SCHEMBL28081101	0.89	GLP1R (0.58)	GLP1RGCGRGIPRTLR2ECE1
SCHEMBL29360549	0.89	GLP1R (0.66)	GLP1RGCGRGIPRTLR2RXFP1
SCHEMBL29655920	0.88	GLP1R (0.67)	GLP1RGCGRGIPRIL23RRXFP1
SCHEMBL29664866	0.88	GLP1R (0.59)	GLP1RGCGRGIPRTLR2ECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
CN-112601811-B	Production of engineered cells and uses thereof	泰莱托恩基金会第三部门组织	2025-04-15	—	—	CN	disclosed
CN-115151636-A	Engineered erythroid cells comprising HLA-G polypeptides and methods of use thereof	鲁比厄斯治疗法股份有限公司	2022-10-04	—	—	CN	disclosed